Neuron23 Inc gathers $113.5m
Neuron23 Inc, an early-stage biotechnology company, has raised $113.5 million in funding.
Neuron23 Inc, an early-stage biotechnology company, has raised $113.5 million in funding.
Copyright PEI Media
Not for publication, email or dissemination